(Q45974680)

English

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giuseppe Signoriello

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Matteo Bassetti

7

object named as

Matteo Bassetti

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Claudio Viscoli

13

object named as

Claudio Viscoli

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

author name string

Emanuele Durante-Mangoni

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Roberto Andini

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Annunziata Mattei

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Maria De Cristoforo

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Patrizia Murino

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Paolo Malacarne

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Nicola Petrosillo

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Nicola Galdieri

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Paola Mocavero

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Antonio Corcione

12

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Raffaele Zarrilli

14

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Ciro Gallo

15

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Riccardo Utili

16

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

language of work or name

0 references

publication date

24 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

57

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

349-358

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Acinetobacter infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Acinetobacter baumannii: emergence of a successful pathogen

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Global spread of carbapenem-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Treatment of Acinetobacter infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin dosing and nephrotoxicity in a large community teaching hospital

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Colistin pharmacokinetics: the fog is lifting

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Nephrotoxicity of intravenous colistin: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Attributable mortality of Acinetobacter baumannii: no longer a controversial issue

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT253

21 January 2018

Identifiers

10.1093/CID/CIT253

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23616495

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45974680&oldid=1886739035"